APNMR 2013* Drug Design & Development
Chair: Kandala Chary
High-affinity cyclic peptide matriptase inhibitors (#9)
11:00 AM
The design of targetable RNA-binding proteins (#10)
11:25 AM
An efficient NMR-based method to generate structural data for protein-ligand complexes that are not amenable to X-ray crystallography (#11)
11:50 AM
Dissecting RAS Cancer Cell Signaling by NMR: New Approach Towards ‘Personalized Medicine’ (#12)
12:05 PM